How much funding has Calico raised?

Calico has raised $2.3B in total funding, most recently a Corporate Round.

Who are Calico's investors?

Calico's investors include Alphabet, AbbVie Ventures, Google.

Where is Calico headquartered?

Calico is headquartered in South San Francisco, California, United States.

What industry is Calico in?

Calico operates in Biotech, Healthcare, Life Sciences.

Calico

Tackling aging, one of life's greatest mysteries

South San Francisco, United States · Founded 2013 · $2.3B raised

Biotech

Healthcare

Life Sciences

Headquarters: South San Francisco, California
Employees: 201–500
Founded: 2013
Business Model: B2B

Website: calicolabs.com
Total Funding: $2.3B
Last Round: $1.0B Corporate RoundJun 2018
Rounds: 4

About

Calico is a research and drug development company dedicated to understanding the biology of aging and translating those insights into potential medicines. The organization integrates basic research, computational biology, machine learning, and advanced laboratory technologies—including cryo-EM, genomics, and mass spectrometry—to advance discoveries toward clinical impact. Calico develops therapeutic approaches targeting age-related diseases including neurodegeneration, cancer, and cardiovascular conditions.

Summary

Calico is a Biotech company based in South San Francisco, United States, founded in 2013. It has raised $2.3B in total across 4 rounds, most recently a $1.0B Corporate Round round in Jun 2018. Investors include Alphabet, AbbVie Ventures and Google.

LinkedIn X (Twitter)GitHub